I apologize, I am having a computer glitch of sorts.
The treatment options vary somewhat, dependant on in-depth medical assessment and goals.
Chemotherapy in varying combinations may be expected.
Radiation treatments
Surgical resection depending on the area of liver involved, and non-liver mets.
Localized treatment options, such as ablation.
Hormonal treatment and/or Immunotherapy may be other options offered
The liver infusion to which you refer is probably: hepatic artery infusion chemotherapy.
A pump is implanted to deliver chemotherapeutic medication directly to the site of the tumor. The early studies showed limited use in breast to liver mets. New/Different mediactions are being tested at this time however.
http://livermets.evidencewatch.com/
Is an excellent site which tracks the newest treatment options of liver mets, (including primary breast to liver)
and their outcomes. This will be a good place for you to begin weighing your options, setting goals and writing a list of questions to be used when discussing your personal treatment options with your Physician.
http://www.clinicaltrials.gov/
Will take you the searchable database of current clinical trials, including those recruiting patients. Searching breast liver mets rtetrieves 6 studies, the following three seemed to relate to your stage of disease, treatment, age etc.
NCT00301106
NCT00001880
NCT00002854
You may search using different variables as well. A printout of the studies which you are interested in reviewing with your Physician should be with your list of questions etc.
Please reply if there is more information I can supply, or part of my answer I may clarify for you. Otherwise, I wish you the best, and hope you will keep in touch with future questions and updates on your health.
Edited by cch771 on June 10 2006 at 2:45 AM
I hope my answer is helpful. If you have more questions, just ask! I am happy to help. If not, please click "accept" so I may receive credit for my work.
Positive feedback and a bonus is appreciated when you feel I've earned it. Thank you, Christy